1. Kambaja B, Dupont S. Amnesia, memory disturbances and epilepsy. Geriatr Psychol Neuropsychiatr Vieil. 2016;14:415–9.
3. Prada Jardim A, Liu J, Baber J, et al. Characterising subtypes of hippocampal sclerosis and reorganization: correlation with pre and postoperative memory deficit. Brain Pathol. 2018;28:143–54.
4. Mishra A, Goel RK. Age dependent learning and memory deficit in Pentylenetetrazol kindled mice. Eur J Pharmacol. 2012;674:315–20.
5. Mishra A, Goel RK. Psychoneurochemical investigations to reveal neurobiology of memory deficit in epilepsy. Neurochem Res. 2013;38:2503–15.
6. Mishra A, Goel RK. Chronic 5-HT3 receptor antagonism ameliorates seizures and associated memory deficit in pentylenetetrazole-kindled mice. Neuroscience. 2016;17:319–28.
7. Bagdy G, Kecskemeti V, Riba P, Jakus R. Serotonin and epilepsy. J Neurochem. 2007;100:857–73.
8. López-Meraz ML, González-Trujano ME, Neri-Bazán L, Hong E, Rocha LL. 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats. Neuropharmacology. 2005;49:367–75.
9. Micheau J, Van Marrewijk B. Stimulation of 5-HT1A receptors by systemic or medial septum injection induces anxiogenic-like effects and facilitates acquisition of a spatial discrimination task in mice. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23:1113–33.
10. Egashira N, Yano A, Ishigami N, et al. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats. Brain Res. 2006;1069:54–62.
11. Xu T, Pandey SC. Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain. Brain Res Bull. 2000;51:499–505.
12. Hidaka N, Suemaru K, Araki H. Serotonin-dopamine antagonism ameliorates impairments of spontaneous alternation and locomotor hyperactivity induced by repeated electroconvulsive seizures in rats. Epilepsy Res. 2010;90:221–7.
13. Mishra A, Goel RK. Adjuvant anticholinesterase therapy for the management of epilepsy-induced memory deficit: a critical pre-clinical study. Basic Clin Pharmacol Toxicol. 2014;115:512–7.
14. Mishra A, Goel RK. Comparative behavioral and neurochemical analysis of phenytoin and valproate treatment on epilepsy induced learning and memory deficit: search for add on therapy. Metab Brain Dis. 2015;30:951–8.
15. Kaster MP, Santos AR, Rodrigues AL. Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test. Brain Res Bull. 2005;67:53–61.
17. Muchimapura S, Mason R, Marsden CA. Effect of isolation rearing on pre- and postsynapticserotonergic function in the rat dorsal hippocampus. Synapse. 2003;47:209–17.
18. Gerber K, Filakovszky J, Halasz P, Bagdy G. The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res. 1998;807:243–5.
19. Graf M, Jakus R, Kantor S, Levay F, Bagdy G. Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy. Neurosci Lett. 2004;359:45–8.
20. Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res. 2008;195:198–213.
21. Hedlund PB, Kelly L, Mazur V, Lovenberg T, Sutcliffe JG, Bonaventure P. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol. 2004;487:125–32.
22. Yang Z, Liu X, Yin Y, Sun S, Deng X. Involvement of 5-HT7 receptors in the pathogenesis of temporal lobe epilepsy. Eur J Pharmacol. 2012;685:52–8.
24. Kecskeméti V, Rusznák Z, Riba P, et al. Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies. Brain Res Bull. 2005;67:126–32.
25. Dreshfield-Ahmad LJ, Thompson DC, Schaus JM, Wong DT. Enhancement in extracellular serotonin levels by 5-hydroxytryptophan loading after administration of WAY 100635 and fluoxetine. Life Sci. 2000;66:2035–41.
26. Lüttgen M, Elvander E, Madjid N, Ogren SO. Analysis of the role of 5-HT1Areceptors in spatial and aversive learning in the rat. Neuropharmacology. 2005;48:830–52.
27. Eriksson TM, Golkar A, Ekström JC, Svenningsson P, Ogren SO. 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. Eur J Pharmacol. 2008;596:107–10.
28. Shen RY, Andrade R. 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus. J Pharmacol Exp Ther. 1998;285:805–12.
29. Maura G, Carbone R, Guido M, Pestarino M, Raiteri M. 5-HT2 presynaptic receptorsmediate inhibition of glutamate release from cerebellar mossy fibre terminals. Eur J Pharmacol. 1991;202:185–90.
30. Behere RV, Anjith D, Rao NP, Venkatasubramanian G, Gangadhar BN. Olanzapine-induced clinical seizure: a case report. Clin Neuropharmacol. 2009;32:297–8.
31. Torta R, Monaco F. Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations. Epilepsia. 2002;43:8–13.
32. Williams GV, Rao SG, Goldman-Rakic PS. The physiological role of 5-HT2A receptors in working memory. J Neurosci. 2002;22:2843–54.
34. Nair SG, Gudelsky GA. Activation of 5-HT2 receptors enhances the release ofacetylcholine in the prefrontal cortex and hippocampus of the rat. Synapse. 2004;53:202–7.